Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martin K.R. Svačina"'
Autor:
Martin K.R. Svačina, Helmar C. Lehmann
Publikováno v:
Neurologie up2date. :271-279
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38db1af667dd8a2a8a58aaa3d1bc9337
https://doi.org/10.1055/a-1163-6617
https://doi.org/10.1055/a-1163-6617
Autor:
Martin K.R. Svačina, Helmar C. Lehmann
Publikováno v:
Current pharmaceutical design. 28(11)
Abstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated polyradiculoneuropathy leading to disability via inflammatory demyelination of peripheral nerves. Various therapeutic approaches with different mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a509db042249aebb6c4766665f9fc147
https://pubmed.ncbi.nlm.nih.gov/35339172
https://pubmed.ncbi.nlm.nih.gov/35339172
Autor:
Gang Zhang, Ilja Bobylev, Kazim A. Sheikh, Martin K.R. Svačina, Philip Röth, Alina Sprenger, Helmar C. Lehmann
Publikováno v:
Journal of Neuroimmune Pharmacology. 14:642-648
Intravenous immunoglobulins (IVIg) are standard treatment for Guillain-Barré syndrome (GBS). Their exact mechanisms of action are versatile and not fully understood. One possible mechanism is neutralization of circulating autoantibodies via binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04f803fd1f6b50513f592d9e691cf10
https://doi.org/10.1007/s11481-019-09871-0
https://doi.org/10.1007/s11481-019-09871-0
Autor:
Man Mohan Mehndiratta, Martin K.R. Svačina, Christian A. Vedeler, Abhijeet R. Joshi, Yogesh Sharma, Helmar C. Lehmann, Ilja Bobylev, Hauke Wüstenberg, Gina Remke, Ines Klein, Alina Sprenger
Publikováno v:
Journal of the neurological sciences. 427
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder causing inflammatory demyelination of peripheral nerves and consecutive disability. Diagnostic criteria and treatments are well established, but it is unknown how clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05598280f4178e01e612192aae2de856
https://pubmed.ncbi.nlm.nih.gov/34130060
https://pubmed.ncbi.nlm.nih.gov/34130060
Publikováno v:
Journal of Neurology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead7c89016be582e9013016cf884d1d2
https://repository.publisso.de/resource/frl:6450288
https://repository.publisso.de/resource/frl:6450288
Autor:
Toni Schneider, Christian Ritter, Abhijeet R. Joshi, Helmar C. Lehmann, Ilja Bobylev, Martin K.R. Svačina
Publikováno v:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 12(1)
Fingolimod is a an oral disease modifying drug for relapsing remitting multiple sclerosis (MS) preventing egress of B and T cells from lymph nodes. Relevant first dose adverse events include bradycardia and atrioventricular conduction slowing. Cardia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547d16a2691b6318e823cff7f75c6c16
https://pubmed.ncbi.nlm.nih.gov/28150133
https://pubmed.ncbi.nlm.nih.gov/28150133